Elbit Systems (ESLT): Backlog Conversion Drives Growth
Elbit Systems is evolving from a wartime demand spike into a backlog-driven growth story, with 2025 revenue up 16% and backlog reaching $28.1B. Strong cash generation, expanding capacity, and improving margins support a constructive view despite rich trailing valuation optics.
Elbit Systems (ESLT) looks like a good investment right now, earning an overall grade of B+ and a Buy rating. The stock is supported by record backlog, rising profitability, and strong cash generation, and our fair value is $930.
Thesis
Elbit Systems Ltd (ESLT) looks like a high-quality defense electronics and systems compounder that has moved from a wartime demand spike into a broader capacity-and-backlog conversion story. The core facts are hard to ignore: 2025 revenue rose 16% to $7.94B, net income climbed to $534.3M from $321.1M in 2024, operating cash flow reached $842.6M, and backlog expanded by $5.5B to $28.1B at year-end 2025. That combination matters because it shows growth is not just headline demand. It is translating into margin expansion, cash generation, and multi-year revenue visibility.
For a balanced, moderate-risk investor, the appeal is straightforward. ESLT sits in several of the most funded defense niches at once: munitions, rocket artillery, electro-optics, electronic warfare, C4I, night vision, and directed energy. Management tied recent growth to Europe, Israel, and North America, with Europe contributing 27% of 2025 revenue and management calling it the primary growth engine going forward. The company is also investing ahead of demand, with 2025 CapEx at $225M and a plan to raise 2026 CapEx to around $300M, mainly for land capacity and electronics assembly.
The main pushback is valuation optics. ESLT trades at 67.6x trailing earnings and a PEG ratio of 8.79, both of which look rich at first glance. But the forward P/E of 9.66 tells a very different story because earnings are scaling quickly. Analyst estimates call for EPS to rise from $10.69 in 2025 to $14.09 in 2026 and $16.59 in 2027, while revenue is projected to reach $9.09B in 2026 and $9.97B in 2027. That makes ESLT less a classic deep-value defense stock and more an execution-driven growth-at-a-reasonable-price case, provided backlog continues to convert and margins keep improving.
The investment view comes down to this: ESLT is not cheap on stale trailing numbers, but it is not expensive if the company keeps doing what it did in 2025. With record backlog, improving profitability, stronger free cash flow, and expanding production capacity, the medium-term setup supports a positive stance. The stock suits investors who can tolerate geopolitical headline risk in exchange for exposure to a defense company with real operating momentum.
Company Overview
▌Common Questions
Frequently asked questions
+Is ESLT stock a buy right now?
Yes, ESLT is a Buy right now. The case rests on a $28.1B backlog, 16% revenue growth in 2025, and improving cash generation that should keep earnings compounding.
+What is ESLT's fair value?
Elbit Systems' fair value is $930. We arrive at that by weighing the company’s 9.66 forward P/E against rapid EPS growth, a $28.1B backlog, and the fact that Europe is now the primary growth engine with 27% of 2025 revenue.
+Why is Elbit Systems growing so fast?
Growth is being driven by ammunition, munition, C4I, and electro-optics demand across Israel, Europe, and North America. The Land segment and ISTAR/EW segment were especially strong in 2025, while backlog rose by $5.5B to $28.1B.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌For Active Investors
Want Reports Like This on Any Stock?
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Elbit Systems Ltd (ESLT) is a global aerospace and defense company headquartered in Haifa, Israel, and listed on NASDAQ. The company was incorporated in 1966, employs 20,537 people, and operates across Israel, North America, Europe, Asia-Pacific, Latin America, and other international markets. Its business spans five operating segments: Aerospace, C4I and Cyber, ISTAR and EW, Land, and Elbit Systems of America.
The product portfolio is broad but coherent. Elbit develops and supplies airborne platforms, unmanned systems, precision-guided munition sensors, aerostructures, training and simulator systems, command-and-control systems, radio communications, cyber intelligence solutions, electro-optic systems, countermeasure systems, naval combat management, electronic warfare, indirect fire systems, turrets and weapons, ammunition, munitions, and active protection systems. In plain English, this is not a single-program company. It is a defense technology platform with exposure to many of the categories governments are funding more aggressively.
Revenue is overwhelmingly product-led. In 2025, product sales were $7.30B, or 91.9% of total revenue, while service revenue was $640.4M, or 8.1%. That mix reflects a company driven primarily by hardware, systems integration, and program delivery rather than a service-heavy model. Still, the installed base and sustainment element matter because defense customers rarely buy once and walk away. Upgrades, support, and follow-on orders are part of the business model.
Geographically, the revenue base is diversified enough to reduce dependence on any single defense budget. In 2025, Israel contributed 32% of revenue, Europe 27%, North America 21%, and Asia-Pacific 16%. Management highlighted that 72% of year-end 2025 backlog came from outside Israel. That is an important detail. ESLT benefits from Israeli demand and battlefield relevance, but the order book is not a one-country story.
Business Segment Deep Dive
Elbit’s segment structure gives a good map of where demand is strongest. The company does not provide full annual segment revenue in the supplied data, but the quarterly trend and management commentary show where momentum is building.
Aerospace covers airborne systems, unmanned solutions, precision-guided munitions, training, simulators, and aviation systems. In Q1 2025, Aerospace external revenue was $448.0M, up from $367.6M a year earlier, and management said the increase was driven mainly by higher precision-guided munition sales in Israel and Asia-Pacific. In Q4 2025, however, Aerospace revenue declined 14% YoY, mainly due to training and simulation in Europe and a tougher comparison against higher PGM sales in Q4 2024. That makes Aerospace a solid business, but not the cleanest growth engine inside the portfolio right now.
C4I and Cyber includes radio systems, command-and-control, communications, and cyber intelligence. In Q1 2025, external revenue reached $204.2M versus $184.5M in Q1 2024, with management citing radio and command-and-control sales in Israel and Europe. In Q4 2025, segment revenue rose 19% YoY, again tied to radio and command-and-control systems in Europe and Israel. This segment matters because modern defense buying is shifting from standalone platforms to networked systems. C4I is the wiring, not the paint.
ISTAR and EW covers intelligence, surveillance, target acquisition, reconnaissance, electro-optics, maritime systems, radar, and electronic warfare. In Q1 2025, external revenue was $303.5M versus $297.2M a year earlier, and management pointed to electro-optic systems in Europe. In Q4 2025, the segment accelerated sharply, with revenue up 39% YoY due to maritime and electro-optic systems, including electronic warfare and counter-UAS solutions. That is one of the clearest signs that ESLT is aligned with current procurement priorities.
Land is the standout. In Q1 2025, external revenue jumped to $539.2M from $360.7M, while management said revenue increased 48% YoY due to ammunition and munition sales in Israel and Europe. In Q4 2025, Land revenue rose another 22% YoY, again driven by ammunition and munition sales in Israel and Europe. Management is directing much of its new capacity spending toward land systems and ammunition production, which is a direct signal about where demand is strongest and where returns on new capital could be highest.
Elbit Systems of America gives the company a local operating footprint in the U.S. market. In Q1 2025, external revenue was $400.9M versus $344.0M in Q1 2024, driven by Warfighter systems and medical instrumentation. In Q4 2025, revenue increased 9% YoY, mainly due to night-vision and maritime systems, partly offset by lower medical device sales. This segment adds strategic value beyond revenue because U.S. defense procurement often favors domestic presence, local manufacturing, and program familiarity.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Two product families stand out as flagship growth drivers: the PULS rocket artillery system and the company’s high-power laser solutions. Both are important because they sit at the intersection of current battlefield demand and future defense modernization spending.
PULS is already proving itself commercially. CEO Bezhalel Machlis said, “Our PULS rocket artillery system continues to be a high runner for Elbit, especially in Europe. Our backlog for this product surpassed the $2 billion mark as more countries selected our agile and technologically advanced system.” That is a meaningful number. A single product family with backlog above $2B inside a company with $7.94B of annual revenue is not a side project. It is a material growth engine.
That open-architecture design is a real selling point. It lowers switching friction for customers that want flexibility across ranges, payloads, and local industrial participation. Machlis also said Elbit has joint ventures and partnership agreements with KNDS and Diehl in Germany and other partners in Europe to develop and produce the solution locally, branded as EuroPULS. That local-production angle matters in Europe, where defense procurement is increasingly tied to domestic industrial policy.
The second flagship area is directed energy. Management highlighted contracts from the Israeli Ministry of Defense for an airborne high-power laser compact jet fighter pod and a high-power laser solution for helicopters. Machlis framed the value proposition clearly: countries are using expensive missiles to defeat low-cost drones and cruise missiles, and that is “not sustainable.” If that problem statement sounds obvious, it is because it is. Defense budgets are large, but even large budgets notice bad economics.
The key here is not that laser revenue is already huge. The key is that Elbit has a credible position in a category that could become much more important if counter-drone warfare keeps expanding. Management said the company overcame major technical challenges in airborne laser targeting and believes the solution can become a new revenue and profit stream in the near future. That is exactly the kind of optionality investors want in a defense name: real programs today, plus a plausible next leg of growth.
Innovation & Competitive Advantage
Elbit’s moat is not one patent or one platform. It is the combination of operationally proven systems, vertical integration, broad domain coverage, and sustained internal R&D. In 2025, net R&D expense was $517M, or 6.5% of revenue, up from $466M in 2024. Management said the increase reflected investment in precision-guided munitions, night vision, and advanced AI capabilities.
That R&D intensity is meaningful because it is being funded from a stronger earnings and cash flow base. The company generated $842.6M in operating cash flow and $598.4M in free cash flow in 2025, based on the annual cash flow statement. Management also described 2025 free cash flow as a record and said it surpassed the $0.5B mark. That means Elbit is not funding innovation from a weak balance sheet or a hope-and-pray capital raise. It is funding it from operations.
The vertical integration angle is just as important. Machlis said Elbit develops its own diodes, detectors, and other components, and that the company has invested with the Israeli Ministry of Defense to become more vertical and “control our destiny.” In defense manufacturing, vertical integration is not just a margin tool. It is a resilience tool. When supply chains tighten, companies with more internal control usually suffer less and deliver more.
The company also benefits from being battle-tested. Management repeatedly described its solutions as aligned with rapidly evolving battlefield needs, and recent demand in munitions, EW, counter-UAS, and command-and-control supports that claim. In defense, operational proof is a sales asset. Governments do not like buying theory when they can buy something already working under pressure.
Operations & Supply Chain
Operations are becoming a bigger part of the ESLT story because demand is no longer the main bottleneck. Capacity is. Management increased 2025 CapEx to $225M and said 2026 CapEx is planned at around $300M. The spending is aimed mainly at land capacity, ammunition and munition production, and electronic assemblies in Israel and abroad.
The most concrete example is the Ramat Beka facility. Management said the company tripled the size of the ammunition and munition factory in southern Israel and expects to start delivering equipment from the facility in 2026. Machlis added that Elbit will have two active production lines in parallel, which should help meet growing demand. This is not abstract strategy language. It is physical throughput expansion.
Another useful detail is customer co-investment. Machlis said some customers are investing alongside Elbit to create additional production capacity, adding that “every dollar that we invest, there is an additional investment by our customers.” That is a strong signal of demand confidence. Customers do not help fund capacity unless they expect to use it.
The supply-chain posture also looks more robust than it did a few years ago. Management said the company increased inventories where needed and used vertical integration to reduce dependence on external suppliers. That matters because 2025 backlog growth of 24% outpaced revenue growth of 16%, and CFO Yaacov Kagan said those figures should converge over time. In other words, the order book is running ahead of current output, and operations are being upgraded to close that gap.
Market Analysis
Elbit operates in a large and fragmented defense market, but the most relevant opportunity is not the entire aerospace complex. It is the faster-growing slices where the company already has traction. External market data in the supplied context points to a defense electronics market of $178.34B in 2025 growing to $234.48B by 2030, and an air defense systems market of $50.86B in 2025 growing to $65.28B by 2030. Those categories line up well with Elbit’s exposure to C4I, EW, electro-optics, counter-UAS, active protection, and directed energy.
The company’s own numbers show it is already capturing that demand. Revenue rose from $5.28B in 2021 to $7.94B in 2025. That is not a one-year jump. It is a four-year scaling trend, with acceleration in 2024 and 2025. Backlog moved from $23.1B as of March 31, 2025 to $28.1B as of December 31, 2025, according to management commentary. That increase suggests demand broadened rather than faded as the year progressed.
Europe is the clearest regional opportunity. Management said Europe contributed 27% of 2025 revenue, surpassing the $2B mark, and called it the primary growth engine going forward, with Germany playing a central role. That is consistent with product commentary around PULS, Iron Fist, DIRCM, radio systems, and electro-optics. Europe is rearming, but not every supplier is equally positioned. Elbit has local subsidiaries, joint ventures, and products already being selected by European customers.
Israel remains a major demand center, contributing 32% of 2025 revenue, while North America contributed 21% and Asia-Pacific 16%. That mix gives Elbit exposure to both urgent replenishment demand and longer-cycle modernization budgets. The market is large enough for growth, and Elbit is already proving it can win in multiple theaters.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
Elbit’s customer base is primarily government and defense-related, which is both a strength and a constraint. The strength is visibility. Governments sign large, multi-year contracts, and the resulting backlog provides unusually clear revenue support. The constraint is that procurement can be political, regulated, and lumpy.
The company emphasizes that it is not dependent on a single country’s defense budget. That claim is supported by 2025 revenue mix and by backlog geography, with 72% of year-end backlog generated from outside Israel. The customer set includes the Israeli Ministry of Defense, the U.S. government, other governments, and commercial and other customers. The 20-F data also indicates customer concentration disclosures tied to Israeli and U.S. government sales, which is typical for a defense contractor of this scale.
The practical customer profile is this: ministries of defense and armed forces that want operationally proven systems, local industrial participation, and integrated solutions. That profile favors suppliers that can deliver across multiple domains and support programs over time. Elbit fits that mold. It is not just selling a box. It is often selling a system, integration work, and a long relationship.
Ownership data adds another angle. Insider ownership stands at 41.294%, while institutional ownership is 23.553%. High insider ownership can align management with long-term value creation, though it also reduces float. Short interest is minimal, with short interest at 0.86% of float and a short ratio of 2.01. That does not signal a market leaning aggressively against the name.
Competitive Landscape
Elbit competes with a long list of global defense companies, including Lockheed Martin, RTX, Northrop Grumman, General Dynamics, L3Harris, BAE Systems, Thales, Leonardo, Saab, Rheinmetall, Hensoldt, Teledyne, AeroVironment, and Israeli peers such as Israel Aerospace Industries and Rafael. That is serious company. ESLT is not winning because the field is weak. It is winning because it plays in categories where speed, integration, and field relevance matter.
Relative to the largest primes, Elbit is smaller and less diversified by platform, but it is often more focused on defense electronics, sensors, EW, munitions, and tactical systems. That can be an advantage. Large primes dominate strategic platforms. Elbit is stronger in the systems that make those platforms smarter, harder to hit, better connected, or more lethal. In modern procurement, those layers are getting more budget attention.
The company’s competitive edge also shows up in how management describes wins. PULS is sold as an open-architecture launcher with local production options. Iron Fist is winning follow-on work for NATO and U.S. Army platforms. High-power laser programs are being positioned as cost-effective responses to drone and missile threats. These are not commodity products. They solve specific operational problems.
One limitation in the supplied data is that the peer valuation screen failed, so there is no clean peer-multiple table to compare ESLT directly against listed competitors. That means the valuation case has to lean more heavily on ESLT’s own forward earnings profile, cash generation, backlog visibility, and analyst targets than on precise peer median comparisons. Even so, the business quality and current growth trajectory compare favorably with what investors usually pay up for in defense.
Macro & Geopolitical Landscape
The macro backdrop for ESLT is unusually supportive because geopolitical tension is feeding directly into defense budgets. Industry data in the supplied context cites global defense expenditures above $2.4T in 2023, with continued support into 2025. Elbit’s own management tied growth to increasing defense budgets globally, particularly in Europe.
This is one of the few sectors where geopolitical stress can strengthen demand visibility instead of weakening it. That does not remove risk. It changes the shape of it. For ESLT, the main macro variable is not consumer spending or industrial PMIs. It is defense procurement urgency, export approvals, and the pace at which governments move from announced budgets to signed contracts.
Israel is a double-edged factor. On one hand, recent conflict has increased demand and reinforced the relevance of Elbit’s systems. Management said the company continued to support the IDF and scale production to meet elevated demand, and cited an additional Israeli defense budget approval of about $13B. On the other hand, Israel exposure brings operational, political, and headline risk. A company can be strategically important and still trade with a geopolitical discount. Markets are funny that way.
Europe offers a cleaner tailwind. Replenishment of munitions, air defense, electronic warfare, and tactical systems has become a multi-year priority across the region. Elbit’s local presence in Germany, Sweden, Romania, and the U.S., plus joint ventures with European partners, helps it turn broad budget increases into actual program wins. That regional diversification reduces the risk that one conflict or one budget cycle defines the whole story.
Balance Sheet Health
▌Subscribers Only
Net debt fell to $1.12B from $1.28B while cash and equivalents rose to $1.13B, leaving Elbit with a stronger liquidity profile even after heavy 2025 investment.
Unlock the full analysis
Subscribers get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
At 67.6x trailing earnings and a PEG of 8.79, Elbit looks expensive on old numbers, but the 9.66 forward P/E reflects how quickly earnings are scaling.
Unlock the full analysis
Subscribers get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Elbit Systems is one of the more interesting defense names in the market because it combines current demand strength with real operating improvement. Too many companies get one without the other. ESLT posted both in 2025: revenue up 16%, net income up sharply, free cash flow at a record, debt down, cash up, and backlog at $28.1B. That is a serious operating year by any standard.
The strategic case is also compelling. The company is exposed to munitions, rocket artillery, EW, C4I, electro-optics, night vision, active protection, and directed energy, all categories that line up with how militaries are spending. Europe is becoming a larger driver, the U.S. footprint remains valuable, and Israel continues to provide both demand and product relevance. Management is not standing still either. It is adding capacity, increasing CapEx, and funding R&D from stronger cash generation.
That does not make ESLT risk-free. It does make it investable. For a moderate-risk investor with a medium-term horizon, the stock still looks attractive below the fair value estimate of $930. The story is no longer about whether demand exists. The story is whether Elbit can keep converting that demand into revenue, margin, and cash at the pace it showed in 2025. Right now, the numbers say it can.
+Is ESLT too expensive after the run-up?
It looks expensive on trailing metrics at 67.6x earnings, but the picture changes with a 9.66 forward P/E and EPS expected to climb from $10.69 in 2025 to $16.59 in 2027. That makes the valuation more reasonable if backlog keeps converting and margins continue to improve.
+What risks should investors watch with ESLT?
The biggest risks are geopolitical headline risk, execution on capacity expansion, and any slowdown in backlog conversion. The company is also spending more on CapEx, with 2026 planned around $300M versus $225M in 2025, so returns on that investment matter.